Merck KGaA, Darmstadt, Germany Announces Favorable UK Court Ruling on Name Use
- Court says MSD breached an agreement with Merck KGaA, Darmstadt, Germany in the UK by using "Merck" alone either as a trade mark or a name
Darmstadt, Germany, January 15, 2016 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced it secured a win in the UK Court following three years of litigation with US-based Merck Sharp & Dohme Corp (MSD) regarding the use of the term "Merck".
In its judgement the English High Court stated that MSD had breached an agreement with the company by using "Merck" alone in the UK either as a trade mark or a name, online or offline. Merck KGaA, Darmstadt, Germany and MSD had entered the agreement in 1955 and amended it in 1970. According to this agreement, Merck KGaA, Darmstadt, Germany is entitled to use the name everywhere in the world, except the U.S. and Canada.
"Our objective has been to protect the status quo established in the existing agreement”, said Friederike Rotsch, General Counsel at Merck KGaA, Darmstadt, Germany. “Therefore, we are pleased that the English court has upheld our argument that MSD’s use of our name and brand 'MERCK' in our territories is beyond the limits agreed with MSD."
Merck KGaA, Darmstadt, Germany relaunched its brand identity last year to reflect the transformation into a global science and technology company with three strong businesses in Healthcare Life Science and Performance Material and create a distinct identity vis-à-vis its patients, customers and investors across various industries and geographies.
The judge said Merck KGaA, Darmstadt, Germany was entitled to an order to prevent MSD from describing itself in any printed or digital material addressed to the UK as "'Merck" alone, and restraining MSD's use of the trade mark "MERCK" alone. The judge also held that MSD’s use of “Merck” as part of branding on its global websites were directed to the UK and infringed Merck KGaA, Darmstadt, Germany’s trade mark rights in the UK.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.kvqryg.live/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the ?Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Merck KGaA, Darmstadt, Germany today announced that updated data from the ongoing, single-arm Phase II VISION study evaluating tepotinib* were published.